The top 5 MassDevice stories of the week — November 6, 2020

The most innovative medical device of 2020. Abbott (NYSE:ABT) received the 2020 Prix Galien USA Award for Best Medical Technology for its MitraClip …

MassDevice Top Five medtech stories weekThe medical device industry continues to move along — with M&A deals made and earnings reported — even as many people focus on the U.S. presidential election.

Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” — as well as fictional monsters that come out of the ocean — during our DeviceTalks Weekly podcast.

Without further ado, here’s this week’s MassDevice Top Five:

5. FDA flags false-positives with COVID-19 antigen tests

FDA is alerting laboratory staff and healthcare providers of false-positive results for rapid COVID-19 antigen tests. Read the full story.

4. The most innovative medical device of 2020

Abbott (NYSE:ABT) received the 2020 Prix Galien USA Award for Best Medical Technology for its MitraClip system. MitraClip, Abbott Park, Ill.-based Abbott’s minimally invasive transcatheter mitral valve repair (TMVR) system, was chosen from a field that included 17 other nominees. Read the full story.

And here’s a roundup of all the nominees.

3. Coloplast sees revenue growth accelerating in 2021, acquires Nine Continents Medical

Coloplast (CPH:COLO-B) was able to boost its annual earnings even as the COVID-19 pandemic held down sales growth — with the Danish medical device giant expecting a stronger 2021. Coloplast also announced that it has completed its acquisition of Nine Continents Medical, an early-state company pioneering an implantable tibial nerve stimulation treatment for overactive bladder. Read the full story.

2. Masimo to acquire Lidco for $40.1M

Masimo (NSDQ:MASI) is set to acquire advanced hemodynamic monitoring device maker Lidco for approximately $40.1 million. Lidco manufactures and sells equipment that measures metrics including cardiac output, stroke volume and systematic vascular resistance, as well as blood monitoring, intravenous fluid monitoring and vasoactive support. Read the full story.

1. Stryker to complete Wright Medical acquisition on November 10

Stryker (NYSE:SYK) has cleared all regulatory hurdles standing in the way of its planned $4.7 billion acquisition of Wright Medical (NSDQ:WMGI). Read the full story.